BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ramesh K Ramanathan, MD
Mayo Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Beatson West of Scotland Cancer Centre
Glasgow, Strathclyde, United Kingdom
- Royal Free London Nhs Foundation Trust
London, United Kingdom
- St Bartholomew'S Hospital
London, United Kingdom
- Banner Health
Gilbert, Arizona, United States
- Mayo Clinic
Phoenix, Arizona, United States
- Global Cancer Research Institute, Inc.
Gilroy, California, United States
- Sarcoma Oncology Research Center
Santa Monica, California, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Atlantic Health System Morristown Medical Center
Morristown, New Jersey, United States
- Vita Medical Associates, P.C.
Bethlehem, Pennsylvania, United States
- Mary Crowley Cancer Research Center
Dallas, Texas, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jul 2016
- Primary completion
- 11 Jun 2019
- Completion
- 11 Jun 2019
- Last update posted
- 26 Mar 2025
- Registered enrollment
- 45
- Registry id
- NCT02650804
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.